Controversies in the management of lentiginous melanoma in situ

References

• Abdelmalek M, Abramova L, Hurt MA, Hruza G. The effectiveness of staged excisions for treating lentiginous melanoma in situ. Expert Rev. Dermatol.3(5) 549–555 (2008).
   Google Scholar
• Forman SB, Ferringer TC, Peckham SJ et al. Is superficial spreading melanoma still the most common form of malignant melanoma? J. Am. Acad. Dermatol.58(6), 1013–1020 (2008).
   PubMed Web of Science ®Google Scholar
• Ferrara G, Zalaudek I, Argenziano G. Lentiginous melanoma: a distinctive clinicopathological entity. Histopathology52(4), 523–525 (2008).
   PubMedGoogle Scholar
• Charles CA, Yee VS, Dusza SW et al. Variation in the diagnosis, treatment, and management of melanoma in situ: a survey of US dermatologists. Arch. Dermatol.141(6), 723–729 (2005).
   PubMedGoogle Scholar
• Davalbhakta A, Hamilton S, Grant JW, Lamberty BG. Spread of a recurrent lentigo maligna into a graft: a case for conservative treatment. Br. J. Plast. Surg.54(3), 253–256 (2001).
   PubMedGoogle Scholar
• Hill DC, Gramp AA. Surgical treatment of lentigo maligna and lentigo maligna melanoma. Australas. J. Dermatol.40(1), 25–30 (1999).
   PubMedGoogle Scholar
• Cohen LM. Lentigo maligna and lentigo maligna melanoma. J. Am. Acad. Dermatol.33, 923–936 (1995).
   PubMed Web of Science ®Google Scholar
• Agarwal-Antal N, Bowen GM, Gerwels JW. Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines. J. Am. Acad. Dermatol.47, 743–748 (2002).
   PubMed Web of Science ®Google Scholar
• Kelly JW. Following lentigo maligna may not prevent the development of life-threatening melanoma. Arch. Dermatol.128(5), 657–660 (1992).
   PubMedGoogle Scholar
• Michalik EE, Fitzpatrick TB, Sober AJ. Rapid progression of lentigo maligna to deeply invasive lentigo maligna melanoma. Report of two cases. Arch. Dermatol.119(10), 831–835 (1983).
   PubMedGoogle Scholar
• Weinstock MA, Sober AJ. The risk of progression of lentigo maligna to lentigo maligna melanoma. Br. J. Dermatol.116, 303–310 (1987).
   PubMed Web of Science ®Google Scholar
• Farshad A, Burg G, Panizzon R, Dummer R. A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft x-rays. Br. J. Dermatol.146(6), 1042–1046 (2002).
   PubMed Web of Science ®Google Scholar
• de Moraes AM, Pavarin LB, Herreros F, de Aguiar Michelman F, Velho PE, de Souza EM. Cryosurgical treatment of lentigo maligna. J. Dtsch. Dermatol. Ges.5(6), 477–480 (2006).
   Google Scholar
• Schmid-Wendtner MH, Brunner B, Konz B et al. Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients. J. Am. Acad. Dermatol.43(3), 477–482 (2000).
   PubMed Web of Science ®Google Scholar
• Kuflik EG, Gage AA. Cryosurgery for lentigo maligna. J. Am. Acad. Dermatol.31, 75–78 (1994).
   PubMedGoogle Scholar
• Niiyama N, Niiyama S, Takasu H, Katsuoka K. Progression of lentigo maligna into lentigo maligna melanoma following laser treatment. Eur. J. Dermatol.17(3), 252–253 (2007).
   PubMedGoogle Scholar
• Zalaudek I, Horn M, Richtig E. Local recurrence in melanoma in situ: influence of sex, age, site of involvement and therapeutic modalities. Br. J. Dermatol.148, 703–708 (2003).
   PubMed Web of Science ®Google Scholar
• Buettiker UV, Yawalkar NY, Braathen LR, Hunger RE. Imiquimod treatment of lentigo maligna: an open-label study of 34 primary lesions in 32 patients. Arch. Dermatol.144(7), 943–945 (2008).
   PubMedGoogle Scholar
• Rajpar SF, Marsden JR. Imiquimod in the treatment of lentigo maligna. Br. J. Dermatol.155, 653–656 (2006).
   PubMed Web of Science ®Google Scholar
• Fisher GH, Lang PG. Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease. Arch. Dermatol.139(7), 945–947 (2003).
   PubMedGoogle Scholar
• Naylor MF, Crowson N, Kuwahara R. Treatment of lentigo maligna melanoma with topical imiquimod. Br. J. Dermatol.149(Suppl. 66), 66–70 (2003).
   PubMed Web of Science ®Google Scholar
• Cotter MA, McKenna JK, Bowen GM. Treatment of lentigo maligna with imiquimod before staged excision. Dermatol. Surg.34(2), 147–151 (2008).
   PubMedGoogle Scholar
• Urist MM, Balch CM, Soong S, Shaw HM, Milton GW, Maddox WA. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer55(6), 1398–1402 (1985).
   PubMed Web of Science ®Google Scholar
• Osborne JE, Hutchinson PE. A follow-up study to investigate the efficacy of initial treatment of lentigo maligna with surgical excision. Br. J. Plast. Surg.55, 611–615 (2002).
   PubMedGoogle Scholar
• Pitman GH, Kopf AW, Bart RS, Casson PR. Treatment of lentigo maligna and lentigo maligna melanoma. J. Dermatol. Surg. Oncol.5, 727–737 (1979).
   PubMedGoogle Scholar
• Coleman WP 3rd, Davis RS, Reed RJ, Krementz ET. Treatment of lentigo maligna and lentigo maligna melanoma. J. Dermatol. Surg. Oncol.6, 476–479 (1980).
   PubMedGoogle Scholar
• Huilgol SC, Selva D, Chen C et al. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision. Arch. Dermatol.140, 1087–1092 (2004).
   PubMedGoogle Scholar
• Robinson JK. Margin control for lentigo maligna. J. Am. Acad. Dermatol.31, 79–85 (1994).
   PubMed Web of Science ®Google Scholar
• Zalla MJ, Lim KK, Dicaudo DJ, Gagnot MM. Mohs micrographic excision of melanoma using immunostains. Dermatol. Surg.26, 771–784 (2000).
   PubMedGoogle Scholar
• Hazan C, Dusza SW, Delgado R, Busam KJ, Halpern AC, Nehal KS. Staged excision for lentigo maligna and lentigo maligna melanoma: a retrospective analysis of 117 cases. J. Am. Acad. Dermatol.58(1), 142–148 (2008).
   PubMed Web of Science ®Google Scholar
• Bene NI, Healy C, Coldiron BM. Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospective study of 167 cases. Dermatol. Surg.34(5), 660–664 (2008).
   PubMed Web of Science ®Google Scholar
• Bub JL, Berg D, Slee A, Odland PB. Management of lentigo maligna and lentigo maligna melanoma with staged excision: a 5-year follow-up. Arch. Dermatol.140(5), 552–558 (2004).
   PubMedGoogle Scholar
• Kimyai-Asadi A, Katz T, Goldberg LH et al. Margin involvement after the excision of melanoma in situ: the need for complete en face examination of the surgical margins. Dermatol. Surg.33(12), 1434–1439 (2007).
   PubMed Web of Science ®Google Scholar
• Walling HW, Scupham RK, Bean AK, Ceilley RI. Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. J. Am. Acad. Dermatol.57(4), 659–664 (2007).
   PubMed Web of Science ®Google Scholar
• Barlow RJ, White CR, Swanson NA. Mohs’ micrographic surgery using frozen sections alone may be unsuitable for detecting single atypical melanocytes at the margins of melanoma in situ. Br. J. Dermatol.146, 290–294 (2002).
   PubMedGoogle Scholar
• Zitelli JA, Brown C, Hanusa BH. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J. Am. Acad. Dermatol.37, 236–245 (1997).
   PubMedGoogle Scholar
• Prieto VG, Argenyi ZB, Barnhill RL et al. Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions? Am. J. Clin. Pathol.120(2), 203–208 (2003).
   PubMed Web of Science ®Google Scholar
• Weyers W, Bonczkowitz M, Weyers I, Bittinger A, Schill WB. Melanoma in situ versus melanocytic hyperplasia in sun-damaged skin. Assessment of the significance of histopathologic criteria for differential diagnosis. Am. J. Dermatopathol.18(6), 560–566 (1996).
   PubMed Web of Science ®Google Scholar
• Hendi A, Brodland DG, Zitelli JA. Melanocytes in long-standing sun-exposed skin: quantitative analysis using the MART-1 immunostain. Arch. Dermatol.142(7), 871–876 (2006).
   PubMedGoogle Scholar
• Bhardwaj SS, Tope WD, Lee PK. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: University of Minnesota experience. Dermatol. Surg.32(5), 690–696 (2006).
   PubMed Web of Science ®Google Scholar
• Kelley LC, Starkus L. Immunohistochemical staining of lentigo maligna during Mohs micrographic surgery using MART-1. J. Am. Acad. Dermatol.46(1), 78–84 (2002).
   PubMedGoogle Scholar
• Dawn ME, Dawn AG, Miller SJ. Mohs surgery for the treatment of melanoma in situ: a review. Dermatol. Surg.33(4), 395–402 (2007).
   PubMedGoogle Scholar
• Bricca GM, Brodland DG, Zitelli JA. Immunostaining melanoma frozen sections: the 1-hour protocol. Dermatol. Surg.30(3), 403–408 (2004).
   PubMed Web of Science ®Google Scholar
• Davis DA, Kurtz KA, Robinson RA. Ultrarapid staining for cutaneous melanoma: study and protocol. Dermatol. Surg.31(7 Pt 1), 753–756 (2005).
   PubMedGoogle Scholar
• Albertini JG, Elston DM, Libow LF, Smith SB, Farley MF. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique. Dermatol. Surg.28(8), 656–665 (2002).
   PubMedGoogle Scholar
• El Shabrawi-Caelen L, Kerl H, Cerroni L. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis. Am. J. Dermatopathol.26(5), 364–366 (2004).
   PubMed Web of Science ®Google Scholar
• Wiltz KL, Qureshi H, Patterson JW, Mayes DC, Wick MR. Immunostaining for MART-1 in the interpretation of problematic intra-epidermal pigmented lesions. J. Cutan. Pathol.34(8), 601–605 (2007).
   PubMed Web of Science ®Google Scholar
• Helm K, Findeis-Hosey J. Immunohistochemistry of pigmented actinic keratoses, actinic keratoses, melanomas in situ and solar lentigines with Melan-A. J. Cutan. Pathol. (2008) (Epub ahead of print).
   Google Scholar
• McKenna JK, Florell SR, Goldman GD, Bowen GM. Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment. Dermatol. Surg.32, 493–504 (2006).
   PubMed Web of Science ®Google Scholar
• Wildemore JK 4th, Schuchter L, Mick R et al. Locally recurrent malignant melanoma characteristics and outcomes: a single-institution study. Ann. Plast. Surg.46(5), 488–494 (2001).
   PubMedGoogle Scholar
• Bevona C, Fewkes J, Liu V, Sober AJ. Prolonged evolution of a lentigo maligna. J. Am. Acad. Dermatol.51(5), 830–835 (2004).
   PubMed Web of Science ®Google Scholar